Phase II study of sequentially administered low-dose mitomycin-C (MMC) and irinotecan (CPT-11) in women with metastatic breast cancer (MBC). (Q40103403)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II study of sequentially administered low-dose mitomycin-C (MMC) and irinotecan (CPT-11) in women with metastatic breast cancer (MBC). |
scientific article |
Statements
1 reference
Phase II study of sequentially administered low-dose mitomycin-C (MMC) and irinotecan (CPT-11) in women with metastatic breast cancer (MBC). (English)
1 reference
E Mrozek
1 reference
J Kolesar
1 reference
D Young
1 reference
J Allen
1 reference
M Villalona-Calero
1 reference
C L Shapiro
1 reference
11 April 2008
1 reference
1 reference
19
1 reference
8
1 reference
1417-1422
1 reference
Identifiers
1 reference
1 reference